GLP-1s such as semaglutide and tirzepatide, originally formulated to treat patients with diabetes, have been touted as a solution for weight loss.
However, these drugs come with some serious side effects – and high price tags – that make 65% of patients taking them for weight loss discontinue them within a year.
In this episode, researcher and patient advocate Ragen Chastain discusses what to know before taking a GLP-1 for weight loss.